| 1 |
X. Lu, T. A. Nguyen, S. H. Moon, Y. Darlington, M. Sommer, and L. A. Donehower, "The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways", Cancer Metastasis Rev., Vol. 27, pp. 123-135, 2008.
DOI
|
| 2 |
H. Yang, X.-Y. Gao, P. Li, and T.-S. Jiang, "PPM1D overexpression predicts poor prognosis in non-small cell lung cancer", Tumour Biology, Vol. 36, pp. 2176-2184, 2015.
|
| 3 |
F. Saito-Ohara, I. Imoto, J. Inoue, H. Hosoi, A. Nakagawara, T. Sugimoto, and J. Inazawa, "PPM1D is a potential target for 17q gain in neuroblastoma", Cancer Res., Vol. 63, pp. 1876-1883, 2003.
|
| 4 |
P. Loukopoulos, T. Shibata, H. Katoh, A. Kokubu, M. Sakamoto, K. Yamazaki, T. Kosuge, Y. Kanai, F. Hosoda, I. Imoto, M. Ohki, J. Inazawa, and S. Hirohashi, "Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome", Cancer Sci., Vol. 98, pp. 392-400, 2007.
DOI
|
| 5 |
R. C. Castellino, M. De Bortoli, X. Lu, S. H. Moon, T. A. Nguyen, M. A. Shepard, P. H. Rao, L. A. Donehower, and J. Y. Kim, "Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D", J Neurooncol., Vol. 86, pp. 245-256, 2008.
DOI
|
| 6 |
M. B. Lambros, R. Natrajan, F. C. Geyer, M. A. Lopez-Garcia, K. J. Dedes, K. Savage, M. Lacroix-Triki, R. L. Jones, C. J. Lord, S. Linardopoulos, A. Ashworth, and J. S. Reis-Filho, "PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study", Mod. Pathol., Vol. 23, pp. 1334-1345, 2010.
DOI
|
| 7 |
J. Parssinen, E. L. Alarmo, S. Khan, R. Karhu, M. Vihinen, and A. Kallioniemi, "Identification of differentially expressed genes after PPM1D silencing in breast cancer", Cancer Lett., Vol. 259, pp. 61-70, 2008.
DOI
|
| 8 |
S. Shreeram, O. N. Demidov, W. K. Hee, H. Yamaguchi, N. Onishi, C. Kek, O. N. Timofeev, C. Dudgeon, A. J. Fornace, C. W. Anderson, Y. Minami, E. Appella, and D. V. Bulavin, "Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways", Mol. Cell, Vol. 23, pp. 757-764, 2006.
DOI
|
| 9 |
L. Jiao, D. Shen, G. Liu, J. Jia, J. Geng, H. Wang, and Y. Sun, "PPM1D as a novel biomarker for prostate cancer after radical prostatectomy", Anticancer Res., Vol. 34, pp. 2919-2925, 2014.
|
| 10 |
S. Nagarajan and T. Madhavan, "Protein phosphatase 1d (ppm1d) structure prediction using homology modeling", J. Chosun Natural Sci., Vol. 9, pp. 35-40, 2016.
DOI
|
| 11 |
S. R. Comeau, D. W. Gatchell, S. Vajda, and C. J. Camacho, "ClusPro: an automated docking and discrimination method for the prediction of protein complexes", Bioinformatics, Vol. 20, pp. 45-50, 2004.
DOI
|
| 12 |
SYBYL Software, Tripos Associates Inc, St. Louis, USA, 2002.
|
| 13 |
A. N. Jain, "Scoring functions for protein-ligand docking", Curr. Protein Pept. Sci., Vol. 7, pp. 407-420, 2006.
DOI
|
| 14 |
A. N. Jain, "Scoring non-covalent protein-ligand interactions: a continuous differentiable function tuned to compute binding", J. Comput. Aided Mol. Des., Vol. 10, pp. 427-440, 1996.
DOI
|
| 15 |
S. R. Comeau, D. W. Gatchell, S. Vajda, and C. J. Camacho, "ClusPro: a fully automated algorithm for protein-protein docking", Nucleic Acids Res., Vol. 32, pp. 96-99, 2004.
|
| 16 |
D. Kozakov, D. Beglov, T. Bohnuud, S. Mottarella, B. Xia, D. Hall, and S. Vajda, "How good is automated protein docking?", Proteins, Vol. 81, pp. 2159-2166, 2013.
DOI
|
| 17 |
M. F. Lensink and S. J. Wodak, "Docking, scoring, and affinity prediction in CAPRI", Proteins, Vol. 81, pp. 2082-2095, 2013.
DOI
|
| 18 |
D. Kozakov, R. Brenke, S. R. Comeau, and S. Vajda S "PIPER: An FFT-based protein docking program with pairwise potentials", Proteins, Vol. 65, pp. 392-406, 2006.
DOI
|
| 19 |
S. Ogasawara, Y. Kiyota, Y. Chuman, A. Kowata, F. Yoshimura, K. Tanino, and R. Kamada, K. Sakaguchi, "Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation", Bioorg. Med. Chem., Vol. 23, pp. 6246-6249, 2015.
DOI
|
webmaster
